Amanda Leach

18.8k total citations · 2 hit papers
192 papers, 6.1k citations indexed

About

Amanda Leach is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Microbiology. According to data from OpenAlex, Amanda Leach has authored 192 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Epidemiology, 55 papers in Pulmonary and Respiratory Medicine and 54 papers in Microbiology. Recurrent topics in Amanda Leach's work include Pneumonia and Respiratory Infections (95 papers), Respiratory viral infections research (78 papers) and Bacterial Infections and Vaccines (52 papers). Amanda Leach is often cited by papers focused on Pneumonia and Respiratory Infections (95 papers), Respiratory viral infections research (78 papers) and Bacterial Infections and Vaccines (52 papers). Amanda Leach collaborates with scholars based in Australia, United States and United Kingdom. Amanda Leach's co-authors include Peter S Morris, Heidi Smith‐Vaughan, John D. Mathews, Kim M. Hare, Marc Lievens, Jemima Beissbarth, V. Asche, Jonathan R. Carapetis, Terry G. Nienhuys and Judith Boswell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Amanda Leach

188 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

2023 158 citations William J. Muller, Joseph B. Domachowske et al. profile →
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

2023 70 citations Deidre Wilkins, Yue Chang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda Leach Australia	43	3.1k	1.4k	1.4k	1.3k	1.1k	192	6.1k
Paola Marchisio Italy	40	2.7k 0.9×	663 0.5×	609 0.4×	1.5k 1.2×	1.2k 1.1×	310	6.0k
Tasnee Chonmaitree United States	43	3.5k 1.1×	641 0.5×	1.1k 0.8×	2.4k 1.9×	2.8k 2.4×	113	6.3k
Stephen I. Pelton United States	56	6.6k 2.1×	880 0.6×	3.4k 2.5×	1.2k 1.0×	1.1k 1.0×	241	10.0k
Jerome O. Klein United States	52	4.8k 1.5×	2.0k 1.4×	2.7k 2.0×	2.7k 2.1×	3.1k 2.7×	260	10.6k
Peter Richmond Australia	51	5.3k 1.7×	767 0.6×	2.9k 2.1×	1.2k 0.9×	429 0.4×	328	8.4k
Terhi Kilpi Finland	37	4.6k 1.5×	628 0.5×	2.7k 2.0×	730 0.6×	703 0.6×	110	5.8k
Charles R. Woods United States	37	1.3k 0.4×	702 0.5×	463 0.3×	1.2k 1.0×	438 0.4×	127	5.7k
Elisabeth A. M. Sanders Netherlands	59	7.5k 2.4×	887 0.6×	3.2k 2.3×	2.3k 1.8×	1.2k 1.0×	284	12.5k
Stan L. Block United States	35	4.0k 1.3×	517 0.4×	990 0.7×	625 0.5×	626 0.5×	128	5.1k
Keith S. Reisinger United States	41	4.5k 1.4×	453 0.3×	1.1k 0.8×	462 0.4×	387 0.3×	108	6.0k

Countries citing papers authored by Amanda Leach

Since Specialization

Citations

This map shows the geographic impact of Amanda Leach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Leach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Leach more than expected).

Fields of papers citing papers by Amanda Leach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Leach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Leach. The network helps show where Amanda Leach may publish in the future.

Co-authorship network of co-authors of Amanda Leach

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Leach. A scholar is included among the top collaborators of Amanda Leach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Leach. Amanda Leach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arbetter, Douglas, Vancheswaran Gopalakrishnan, Anastasia A. Aksyuk, et al.. (2024). Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY). Clinical Infectious Diseases. 81(3). 634–644. 6 indexed citations

Reath, Jennifer, Sarah O’Brien, Hasantha Gunasekera, et al.. (2024). The views of parents and carers on managing acute otitis media in urban Aboriginal and Torres Strait Islander children: a qualitative study. The Medical Journal of Australia. 220(4). 202–207. 1 indexed citations

Wilkins, Deidre, Ulrika Wählby Hamrén, Lindsay E. Clegg, et al.. (2024). RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing. PEDIATRICS. 154(5). 12 indexed citations

Pelton, Stephen I., Amanda Leach, Paola Marchisio, et al.. (2023). ISOM 2023 Research Panel 5: Interventions- Vaccines and prevention, medical and surgical treatment, and impact of COVID-19 pandemic. International Journal of Pediatric Otorhinolaryngology. 176. 111782–111782. 2 indexed citations

Binks, Michael, Susan J. Pizzutto, Jane Nelson, et al.. (2023). Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol. BMJ Open Respiratory Research. 10(1). e001646–e001646. 6 indexed citations

Oguoma, Victor M., Tahmina Begum, E. D. Dyson, et al.. (2023). Trajectories of otitis media and association with health determinants among Indigenous children in Australia: the Longitudinal Study of Indigenous Children. Public Health. 225. 53–62. 3 indexed citations

Danchin, Margie, Mark Jones, Amanda Leach, et al.. (2022). Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial. The Journal of Infectious Diseases. 226(9). 1537–1544. 5 indexed citations

Reath, Jennifer, Hasantha Gunasekera, Amanda Leach, et al.. (2022). INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children. Trials. 23(1). 309–309. 1 indexed citations

Abbott, Penelope, Deborah Askew, Wendy Hu, et al.. (2021). Randomised clinical trial research within Aboriginal and Torres Strait Islander primary health services: a qualitative study. BMJ Open. 11(12). e050839–e050839. 4 indexed citations

10.

He, Vincent Yaofeng, et al.. (2020). The link between hearing impairment and child maltreatment among Aboriginal children in the Northern Territory of Australia: is there an opportunity for a public health approach in child protection?. BMC Public Health. 20(1). 449–449. 9 indexed citations

11.

Oguoma, Victor M., Kim Mulholland, Mathuram Santosham, et al.. (2020). 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial. BMJ Open. 10(5). e033511–e033511. 3 indexed citations

12.

Cicconi, Paola, Claire Jones, Laura Silva-Reyes, et al.. (2019). First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Clinical Infectious Diseases. 70(10). 2073–2081. 43 indexed citations

13.

Beissbarth, Jemima, Heidi Smith‐Vaughan, Tegan M. Harris, Michael Binks, & Amanda Leach. (2019). Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene. Vaccine. 37(30). 4089–4093. 3 indexed citations

14.

He, Vincent Yaofeng, et al.. (2019). Hearing and justice: The link between hearing impairment in early childhood and youth offending in Aboriginal children living in remote communities of the Northern Territory, Australia. Health & Justice. 7(1). 16–16. 14 indexed citations

15.

Cicconi, Paola, Claerwen M. Jones, Laura Silva-Reyes, et al.. (2019). First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.. Clinical Infectious Diseases. 4 indexed citations

16.

Jones, Mark, Claire S. Waddington, Margie Danchin, et al.. (2019). The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis. BMJ Open. 9(11). e032549–e032549. 11 indexed citations

17.

Binks, Michael, Sarah Moberley, Anne Balloch, et al.. (2018). Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia. SHILAP Revista de lepidopterología. 10(1). 13–13. 7 indexed citations

18.

Beissbarth, Jemima, Michael Binks, Robyn L. Marsh, et al.. (2018). Recommendations for application of Haemophilus influenzae PCR diagnostics to respiratory specimens for children living in northern Australia: a retrospective re-analysis. BMC Research Notes. 11(1). 323–323. 3 indexed citations

19.

Leach, Amanda, Kim Mulholland, M Santosham, et al.. (2015). Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial. BMJ Open. 5(1). e007247–e007247. 22 indexed citations

20.

Balloch, Anne, Paul V. Licciardi, Andrew S. Kemp, et al.. (2014). Comparison of Anti-pneumococcal Antibodies in Cord Blood From Australian Indigenous and Gambian Neonates and the Implications for Otitis Media. The Pediatric Infectious Disease Journal. 33(4). e116–e120. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact